1. 10Z-Hymenialdisine Inhibits Angiogenesis by Suppressing NF-κB Activation in Pancreatic Cancer Cell Lines. (2022) Authors: Ueda, G.; Matsuo, Y.; Murase, H.; Aoyama, Y.; Kato, T.; Omi, K.; Hayashi, Y.; Imafuji, H.; Saito, K.; Tsuboi, K.; Morimoto, M.; Ogawa, R.; Takahashi, H.; Takiguchi, S. Journal: HPB Issue: Volume 24(2022)Supplement 1 Page Start: S259 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 1616 A double blind, self-controlled randomized trial of prophylactic topical vitamin K1 cream application for cetuximab-related skin toxicity (VANQUISH trial). (September 2015) Authors: Tsushima, T.; Yamazaki, K.; Kato, T.; Taku, K.; Yoshida, Y.; Hamauchi, S.; Yoshikawa, S.; Yagi, H.; Kimura, M.; Ishikawa, H.; Kimura, M.; Nakajo, M.; Sakata, S.; Masujima, H.; Miyazawa, A.; Saitou, K.; Izawa, M.; Iwami, K.; Yamanaka, T.; Kiyohara, Y. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S243 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 1853 Phase I study of combination therapy with weekly nanoparticle albumin-bound paclitaxel and cyclophosphamide in patients with advanced or recurrent breast cancer. (September 2015) Authors: Ota, D.; Akatsuka, S.; Nishi, T.; Kato, T.; Takeuchi, M.; Munechika, T.; Inagaki, M.; Fukuuchi, A. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S283 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. 2035 Diffusion-weighted magnetic resonance imaging for the prediction of the tumor response to neoadjuvant chemoradiotherapy using irinotecan plus S-1 for rectal cancer. (September 2015) Authors: Doi, H.; Beppu, N.; Kato, T.; Tanooka, M.; Kengo, K.; Tarutani, K.; Suzuki, H.; Odawara, S.; Niwa, Y.; Takada, Y.; Fujiwara, M.; Noda, M.; Tomita, N.; Kamikonya, N.; Hirota, S. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S340 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. 2092 Updated analysis: Observational cohort study of 1st line bevacizumab combined with chemotherapy in metastatic colorectal cancer (HGCSG0802): Comparison of infusional FU/oxaliplatin(OX)+BV and oral FU/OX+BV. (September 2015) Authors: Nakatsumi, H.; Yuki, S.; Kawamoto, Y.; Muranaka, T.; Hatanaka, K.; Kato, T.; Meguro, T.; Nakamura, M.; Iwanaga, I.; Uebayashi, M.; Tateyama, M.; Eto, K.; Kudo, M.; Kato, S.; Okuda, H.; Sogabe, S.; Miyashita, K.; Sakata, Y.; Sakamoto, N.; Komatsu, Y. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S358 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. 2096 Phase II trial of Irinotecan plus S-1 (IRIS) with Cetuximab (IRIS/Cet) in pre-treated patients with KRAS wild type of metastatic colorectal cancer (mCRC): HGCSG0902 updated analysis. (September 2015) Authors: Nakamura, M.; Yuki, S.; Nakatsumi, H.; Muto, O.; Hosokawa, A.; Kato, T.; Iwanaga, I.; Hatanaka, K.; Tsuji, Y.; Sato, A.; Eto, K.; Furukawa, K.; Okuda, H.; Onodera, M.; Fujikawa, K.; Kudo, M.; Yokoyama, S.; Honda, T.; Sakata, Y.; Komatsu, Y. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S360 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. 2099 Association of morphologic response with overall survival in patients with metastatic colorectal cancer treated with bevacizumab-based chemotherapy: Updated analysis - HGCSG0802. (September 2015) Authors: Yagisawa, M.; Yuki, S.; Muranaka, T.; Sawada, K.; Hatanaka, K.; Kato, T.; Meguro, T.; Nakamura, M.; Iwanaga, I.; Eto, K.; Sato, A.; Okuda, H.; Kato, K.; Miyagishima, T.; Muto, O.; Yabusaki, S.; Miyamoto, N.; Kudo, K.; Sakata, Y.; Komatsu, Y. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S361 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. 2232 Results of the preoperative diagnosis by staging laparoscopy and the surgical intervention following chemotherapy for patients with peritoneal dissemination due to gastric cancer. (September 2015) Authors: Tamura, S.; Takeno, A.; Murakami, K.; Naito, A.; Katsura, Y.; Ohmura, Y.; Kagawa, Y.; Okishiro, M.; Egawa, C.; Takeda, Y.; Kato, T. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S410 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. 394PA self-controlled trial of prophylactic topical application of vitamin K1 cream for cetuximab-related skin rash. (19th December 2015) Authors: Ishikawa, H.; Kato, T.; Yamazaki, K.; Taku, K.; Tsushima, T.; Yoshida, Y.; Hamauchi, S.; Yoshikawa, S.; Yagi, H.; Kimura, M.; Kimura, M.; Nakajo, M.; Sakata, S.; Masujima, H.; Miyazawa, A.; Izawa, M.; Iwami, K.; Yamanaka, T.; Kiyohara, Y. Journal: Annals of oncology Issue: Volume 26(2015)Supplement 9 Page Start: ix118 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. 609 Pravastatin protects normal intestinal epithelium and normal lung from radiation-induced cell death. (September 2015) Authors: Doi, H.; Odawara, S.; Matsumoto, S.; Shikata, T.; Suzuki, H.; Kato, T.; Tarutani, K.; Kosaka, K.; Inoue, H.; Tanooka, M.; Takada, Y.; Tsujimura, T.; Kamikonya, N.; Hirota, S. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S119 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗